Their latest clinical trial mentions a "full spectrum" microbiome therapeutic, which would support this: https://pubmed.ncbi.nlm.nih.gov/39366468/
The question I would have is, what's the difference between the various products in their pipeline (CP101, FIN-524, FIN-525, FIN-211)? Are some of...